GeneThera AI
Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $20M
Overview
An AI-powered gene therapy company focused on optimizing treatments for rare genetic diseases.
Rare Genetic DiseasesGene Therapy
Technology Platform
An integrated AI platform designed to optimize gene therapy vector design, predict efficacy, and identify optimal patient populations for rare diseases.
Funding History
1Total raised:$20M
Public Offering$20M
Opportunities
Potential to significantly de-risk and accelerate the development of gene therapies for high-need rare diseases.
Risk Factors
Technical risk of successfully integrating two complex technologies and demonstrating clear clinical advantage.
Competitive Landscape
Occupies a specialized niche, competing with broader AI drug discovery firms and gene therapy companies developing internal computational capabilities.